Cover Image


Bio-Printing Markets: A Ten-Year Opportunity Forecast

出版商 SmarTech Markets Publishing LLC 商品編碼 292882
出版日期 內容資訊 英文
Back to Top
生物印刷市場:10年的機會預測 Bio-Printing Markets: A Ten-Year Opportunity Forecast
出版日期: 2014年01月14日 內容資訊: 英文



第1章 生物印刷技術

  • 生物印刷流程
    • 生物學的雷射印刷
    • 雷射直寫(雷射輔助)
    • ADE(Acoustic Droplet Ejection )
    • 生物繪圖
    • 噴墨
    • 未來價值的促進要素
    • 硬體設備標準化的請求
  • 生物印刷軟體
    • 4D Analysis
    • AutoCAD
    • Materialise
    • Amira
    • 與調查計劃合作的重要性
    • 新的生物印刷編碼
  • 生物印刷材料
    • 生物分解性框架
    • 水凝膠
    • 新材料的動機
    • 細胞培養
    • 商業化要求細胞培養的創新

第2章 商業機會

  • 政府的財政援助
  • VC及民間投資
  • 作成朝向創新的藍圖
  • 機會時間軸
    • 新的藥物篩檢
    • 局部藥物治療
    • 豐胸
    • 生物印刷組織
    • 內臟器官治療
    • 3D印刷心臟的展望

第3章 下一個十年的創新問題

  • 生物印刷的血管系統的障礙的指南
  • 生物印刷和醫學界之間的裂縫
  • 發展藍圖向商業化
  • 流程標準化的要求
  • 專用生物印刷硬體設備、軟體及材料的時間
Product Code: SMP-BPM-0114

Bio-printing is a young but emerging field of study, whose ramifications are increasingly commercial. Promises of 3D-printed organs may catch the attention of the media, but the time has come for the wider market to take notice as well. More imminent applications of bio-printing technology will drive growth and galvanize bio-printing into a real industry over the next decade. This industry will require dedicated hardware, software, and materials that suite its needs, and present considerable revenue opportunities.

Bio-printing may only be a blip on the screen of many executives now, but this industry is flying below the radar. It is time for the business community to take notice of bio-printing: to make efforts towards understanding exactly how what it will do and what opportunities it represents.

In this report, SmarTech identifies the current state of the bio-printing sector though an analysis of processes, software, and materials employed by the industry. More than simply an industry survey, this report focuses on the strategies employed in the bio-printing market through an analysis of key players. Readers of the report will gain an understanding of the dynamics of the industry as it stands today, as well as a framework for contextualizing new developments.

The second half of the report discusses the commercial applications of bio-printing today and in the future. We have organized bio-printing opportunities on our own timeline; from the most realizable to the most distant. This discussion spans across tissues for drug testing and drug qualification, localized medicinal therapies, breast augmentation, bio-printed tissues, and total organ replacement.

Each opportunity is thoroughly analyzed, providing the reader with a clear understanding of technological progress, market size, timing to market, and associated risks. We have also included a discussion of the sources of current and future funding for bio-printing, which helps the reader understand what will keep the fire burning as bio-printing approaches these more dramatic commercial opportunities.

This report concludes with a discussion of the five biggest challenges that bio-printing will face over the next decade. It is critical these issues be addressed by all stakeholders in bio-printing, as the trajectory of the industry ultimately hinges on their successful resolution.

SmarTech believes that this report will provide invaluable guidance for material, software, and equipment manufacturing companies in the bio-medical industry, 3D printing industry, and other related sectors. This report will also interest specialty chemical firms, cell culturers, and forward-thinking medical professionals, clinics and laboratories. We also think that this report will prove to be required reading for investors in the budding bio-printing sector.

Table of Contents

Chapter 1: Bio-Printing Technology

  • 1.1 Bio-Printing Processes
    • 1.1.1 Biological Laser Printing
    • 1.2.1 Laser Direct Write (Laser Assisting)
    • 1.3.1 Acoustic Droplet Ejection
    • 1.4.1 Bio-Plotting
    • 1.5.1 Inkjet
    • 1.6.1 Drivers of Future Value
    • 1.7.1 The Plea For Hardware Standardization
  • 1.2 Bio-Printing Software
    • 1.2.1 4D Analysis
    • 1.2.2 AutoCAD
    • 1.2.3 Materialise
    • 1.2.4 Amira
    • 1.2.5 The Importance of Partnerships With Research Programs
    • 1.2.6 The New Bio-Printing Code
  • 1.3 Bio-Printing Materials
    • 1.3.1 Biodegradable Lattices
    • 1.3.2 Hydrogels
    • 1.3.3 The Drive Towards New Materials
    • 1.3.4 Cell Cultures
    • 1.3.5 Commercialization Demands Innovation In Cell Culturing

Chapter 2: Commercial Opportunities

  • 2.1 Government Funding
  • 2.2 VC and Private Investment
  • 2.3 Creating a Roadmap Towards Innovation
  • 2.4 Opportunity Timeline
    • 2.4.1 New Drug Screening
    • 2.4.2 Localized Medicinal Therapies
    • 2.4.3 Breast Augmentation
    • 2.4.4 Bio-Printed Tissues
    • 2.4.5 Organ Therapies
    • 2.4.6 Prospects For The 3D Printed Heart

Chapter 3: 5 Core Issues For The Next Ten Years

  • 3.1 Navigating The Bottleneck of Bio-Printed Vasculature
  • 3.2 The Rift Between Bio-Printing And The Practicing Medical Community
  • 3.3 The Roadmap To Commercialization
  • 3.4 The Call For Process Standardization
  • 3.5 The Time For Dedicated Bio-Printing Hardware, Software, and Materials
Back to Top